| |
| |
|
| Insider
Information: |
Raab Michael |
| Relationship: |
|
| City: |
Baltimore |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,353,869 |
|
|
Indirect Shares
|
25,364 |
|
|
| Direct
Value |
$9,601,026 |
|
|
|
Indirect Value
|
$173,997 |
|
|
| Total
Shares |
1,379,233 |
|
|
| Total
Value |
$9,775,023 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
16
|
|
Stock
price went up :
|
1
|
11
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
2.2
|
| Percentage
Gain/Loss : |
 276.6%
|
1,415.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ardelyx Inc |
ARDX |
President & CEO, Direc... |
2024-05-29 |
1,270,273 |
2024-05-29 |
25,364 |
Premium* |
|
|
Amicus Therapeutics Inc |
FOLD |
|
2024-03-05 |
83,596 |
2015-06-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
78 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARDX |
Ardelyx Inc |
President & CEO |
• • – |
2020-03-02 |
4 |
AS |
$7.00 |
$77,861 |
D/D |
(11,123) |
208,057 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
President & CEO |
• • – |
2020-03-02 |
4 |
AS |
$7.01 |
$143,284 |
I/I |
(20,428) |
110,240 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
President & CEO |
• • – |
2020-04-15 |
4 |
AS |
$7.03 |
$3,515 |
I/I |
(500) |
109,740 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
President & CEO |
• • – |
2020-04-16 |
4 |
AS |
$7.01 |
$73,642 |
I/I |
(10,500) |
99,240 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
President & CEO |
• • – |
2020-04-17 |
4 |
AS |
$7.02 |
$66,169 |
I/I |
(9,428) |
89,812 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
President & CEO |
• • – |
2020-05-04 |
4 |
AS |
$7.01 |
$111,686 |
I/I |
(15,941) |
73,871 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
President & CEO |
• • – |
2020-05-05 |
4 |
AS |
$7.03 |
$31,536 |
I/I |
(4,486) |
69,385 |
0 |
% |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2020-06-01 |
4 |
AS |
$12.65 |
$63,261 |
D/D |
(5,000) |
15,145 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
President & CEO |
• • – |
2020-06-01 |
4 |
AS |
$7.33 |
$169,635 |
I/I |
(23,128) |
46,257 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
President & CEO |
• • – |
2020-07-02 |
4 |
AS |
$7.01 |
$162,130 |
I/I |
(23,128) |
24,364 |
0 |
% |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2022-05-02 |
4 |
AS |
$6.99 |
$104,891 |
D/D |
(15,000) |
36,749 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
President & CEO |
• • – |
2024-04-01 |
4 |
AS |
$7.31 |
$11,097 |
D/D |
(1,518) |
1,318,433 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
President & CEO |
• • – |
2024-04-15 |
4 |
AS |
$7.06 |
$52,924 |
D/D |
(7,500) |
1,310,933 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
President & CEO |
• • – |
2024-04-29 |
4 |
AS |
$6.40 |
$192,057 |
D/D |
(30,000) |
1,310,933 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
President & CEO |
• • – |
2024-05-14 |
4 |
AS |
$7.99 |
$23,970 |
D/D |
(3,000) |
1,307,933 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
President & CEO |
• • – |
2024-05-29 |
4 |
AS |
$6.72 |
$50,390 |
D/D |
(7,500) |
1,270,273 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
President & CEO |
• • – |
2022-08-31 |
4 |
B |
$0.62 |
$1,856 |
D/D |
3,000 |
665,680 |
2.73 |
% |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2015-06-08 |
4 |
D |
$12.65 |
$113,040 |
D/D |
(8,936) |
0 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
President & CEO |
• • – |
2021-08-03 |
4 |
D |
$1.64 |
$246,563 |
D/D |
(150,343) |
332,303 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
President and CEOOfficer |
• • – |
2014-06-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
83,658 |
|
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2017-10-12 |
4 |
OE |
$14.25 |
$142,534 |
D/D |
10,000 |
15,814 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2018-01-02 |
4 |
OE |
$15.00 |
$140,490 |
D/D |
9,366 |
15,180 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2018-04-16 |
4 |
OE |
$10.53 |
$52,650 |
D/D |
5,000 |
10,814 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Director |
– • – |
2019-06-03 |
4 |
OE |
$7.15 |
$35,750 |
D/D |
5,000 |
13,895 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
President & CEO |
• • – |
2020-02-05 |
4 |
OE |
$1.08 |
$27,000 |
D/D |
25,000 |
231,828 |
0 |
- |
|
78 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
